US Patent 10266608 Fabs-in-tandem immunoglobulin and uses thereof
Patent 10266608 was granted and assigned to EpimAb Biotherapeutics on April, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10266608 Fabs-in-tandem immunoglobulin and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
